Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:2276-2285
doi: 10.1161/CIRCULATIONAHA.105.536433
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fuse, K.
Right arrow Articles by Liu, P. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fuse, K.
Right arrow Articles by Liu, P. P.
Related Collections
Right arrow Other myocardial biology
Right arrow Congestive
Right arrow Animal models of human disease
Right arrow Heart failure - basic studies
Right arrow Physiological and pathological control of gene expression

(Circulation. 2005;112:2276-2285.)
© 2005 American Heart Association, Inc.


Heart Failure

Myeloid Differentiation Factor-88 Plays a Crucial Role in the Pathogenesis of Coxsackievirus B3–Induced Myocarditis and Influences Type I Interferon Production

Koichi Fuse, MD, PhD; Grace Chan, BSc; Youan Liu, MD, MSc; Patrick Gudgeon, BSc; Mansoor Husain, MD; Manyin Chen, MD, MSc; Wen-Chen Yeh, MD, PhD; Shizuo Akira, MD, PhD; Peter P. Liu, MD

From the Heart and Stroke/Richard Lewar Centre of Excellence, University of Toronto, and Division of Cardiology, University Health Network, Toronto, Canada (K.F., G.C., Y.L., P.G., M.H., M.C., P.P.L.); Ontario Cancer Institute and Department of Medical Biophysics, University of Toronto (W.-C.Y.), Toronto, Canada; and the Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan (S.A.).

Correspondence to Peter P. Liu, MD, Heart and Stroke/Richard Lewar Centre of Excellence, NCSB11-1266, Toronto General Hospital, 200 Elizabeth St, Toronto, Ontario, M5G 2C4, Canada. E-mail peter.liu{at}utoronto.ca

Received January 18, 2005; revision received May 7, 2005; accepted June 17, 2005.

Background— Myeloid differentiation factor (MyD)-88 is a key adaptor protein that plays a major role in the innate immune pathway. How MyD88 may regulate host response in inflammatory heart disease is unknown.

Methods and Results— We found that the cardiac protein level of MyD88 was significantly increased in the hearts of wild-type mice after exposure to Coxsackievirus B3 (CVB3). MyD88–/– mice showed a dramatic higher survival rate (86%) in contrast to the low survival (35%) in the MyD88+/+ mice after CVB3 infection (P<0.0001). Pathological examination showed a significant decrease of cardiac and pancreatic inflammation in the MyD88–/– mice. Viral concentrations in the hearts were significantly decreased in the MyD88–/– mice. Cardiac mRNA levels for interleukin (IL)-1ß, tumor necrosis factor (TNF)-{alpha}, interferon (IFN)-{gamma}, and IL-18 were significantly decreased in the MyD88–/– mice. Similarly, serum levels of T-helper 1 cytokines were significantly decreased in the MyD88–/– mice. In contrast, cardiac protein levels of the activated interferon regulatory factor (IRF)-3 and IFN-ß were significantly increased in the MyD88–/– mice but not other usual upstream signals to IRF-3. The cardiac expression of coxsackie-adenoviral receptor and p56lck were also significantly decreased.

Conclusions— MyD88 appears to be a key contributor to cardiac inflammation, mediating cytokine production and T-helper-1/2 cytokine balance, increasing coxsackie-adenoviral receptor and p56lck expression and viral titers after CVB3 exposure. Absence of MyD88 confers host protection possibly through novel direct activation of IRF-3 and IFN-ß.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Circ. Res.Home page
P. Blyszczuk, G. Kania, T. Dieterle, R. R. Marty, A. Valaperti, C. Berthonneche, T. Pedrazzini, C. T. Berger, S. Dirnhofer, C. M. Matter, et al.
Myeloid Differentiation Factor-88/Interleukin-1 Signaling Controls Cardiac Fibrosis and Heart Failure Progression in Inflammatory Dilated Cardiomyopathy
Circ. Res., October 23, 2009; 105(9): 912 - 920.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Maekawa, N. Mizue, A. Chan, Y. Shi, Y. Liu, S. Dawood, M. Chen, F. Dawood, G. de Couto, G. H. Li, et al.
Survival and Cardiac Remodeling After Myocardial Infarction Are Critically Dependent on the Host Innate Immune Interleukin-1 Receptor-Associated Kinase-4 Signaling: A Regulator of Bone Marrow-Derived Dendritic Cells
Circulation, October 6, 2009; 120(14): 1401 - 1414.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Yajima and K. U. Knowlton
Viral Myocarditis: From the Perspective of the Virus
Circulation, May 19, 2009; 119(19): 2615 - 2624.
[Full Text] [PDF]


Home page
NEJMHome page
L. T. Cooper Jr.
Myocarditis
N. Engl. J. Med., April 9, 2009; 360(15): 1526 - 1538.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Shi, C. Chen, U. Lisewski, U. Wrackmeyer, M. Radke, D. Westermann, M. Sauter, C. Tschope, W. Poller, K. Klingel, et al.
Cardiac deletion of the coxsackievirus-adenovirus receptor abolishes coxsackievirus b3 infection and prevents myocarditis in vivo.
J. Am. Coll. Cardiol., April 7, 2009; 53(14): 1219 - 1226.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. O. Weinzierl, G. Szalay, H. Wolburg, M. Sauter, H.-G. Rammensee, R. Kandolf, S. Stevanovic, and K. Klingel
Effective Chemokine Secretion by Dendritic Cells and Expansion of Cross-Presenting CD4-/CD8+ Dendritic Cells Define a Protective Phenotype in the Mouse Model of Coxsackievirus Myocarditis
J. Virol., August 15, 2008; 82(16): 8149 - 8160.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Riad, S. Jager, M. Sobirey, F. Escher, A. Yaulema-Riss, D. Westermann, A. Karatas, M. M. Heimesaat, S. Bereswill, D. Dragun, et al.
Toll-Like Receptor-4 Modulates Survival by Induction of Left Ventricular Remodeling after Myocardial Infarction in Mice
J. Immunol., May 15, 2008; 180(10): 6954 - 6961.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Khaleduzzaman, J. Francis, M. E. Corbin, E. McIlwain, M. Boudreaux, M. Du, T. W. Morgan, and K. E. Peterson
Infection of Cardiomyocytes and Induction of Left Ventricle Dysfunction by Neurovirulent Polytropic Murine Retrovirus
J. Virol., November 15, 2007; 81(22): 12307 - 12315.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. P. Wang, D. R. Asher, M. Chan, E. A. Kurt-Jones, and R. W. Finberg
Cutting Edge: Antibody-Mediated TLR7-Dependent Recognition of Viral RNA
J. Immunol., March 15, 2007; 178(6): 3363 - 3367.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Maekawa, M. Ouzounian, M. A. Opavsky, and P. P. Liu
Connecting the Missing Link Between Dilated Cardiomyopathy and Viral Myocarditis: Virus, Cytoskeleton, and Innate Immunity
Circulation, January 2, 2007; 115(1): 5 - 8.
[Full Text] [PDF]


Home page
Infect. Immun.Home page
A. K. Behera, E. Hildebrand, R. T. Bronson, G. Perides, S. Uematsu, S. Akira, and L. T. Hu
MyD88 Deficiency Results in Tissue-Specific Changes in Cytokine Induction and Inflammation in Interleukin-18-Independent Mice Infected with Borrelia burgdorferi
Infect. Immun., March 1, 2006; 74(3): 1462 - 1470.
[Abstract] [Full Text] [PDF]